Atrion Corporation - Wutah dodolan YoY (TTM) ATRI

Atrion Corporation (ATRI) year-over-year product sales volume dynamics for the TTM reflect the impact of polymer volatility and dependence on the US healthcare sector, with the -7.00 indicator determining the metric's magnitude. The business relies on the production of gold-standard fluid delivery systems for ophthalmology, complementing them with the systematic refinement of cardiac catheter designs within strict industry regulations.
Atrion Corporation - rincian analitis lan metrik utama (ATRI)

This metric measures rolling year revenue dynamics, allowing investors to assess business expansion rates and the volatility of operating flows. By analyzing the historical year-over-year revenue growth trend over the last 12 months, one can gauge the stability of demand for high-tech ophthalmology and cardiology instruments, which confirms the market resilience of Atrion Corporation (ATRI) within the critical medical device segment.